Man Group PLC Ptc Therapeutics, Inc. Transaction History

Man Group PLC

$37.2 Billion
Q1 2025

A detailed history of Man Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 260,860 shares of PTCT stock, worth $12.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

260,860

Holding current value

$12.3 Million

% of portfolio

0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$41.81 - $57.17 $10.9 Million - $14.9 Million	260,860 New	260,860 $13.3 Million
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $9.29 Million - $15.1 Million	-514,143 Reduced 98.15%	9,700 $267,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $11.5 Million - $21.5 Million	512,617 Added 4566.34%	523,843 $11.7 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $453,530 - $663,456	11,226 New	11,226 $456,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $6.36 Million - $10.4 Million	189,561 New	189,561 $7.24 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $169,420 - $299,332	6,618 Added 27.23%	30,924 $1.24 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $810,118 - $1.08 Million	24,306 New	24,306 $907,000
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $1.47 Million - $1.91 Million	-38,669 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $1.7 Million - $2.5 Million	-36,263 Reduced 48.39%	38,669 $1.83 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $956,754 - $1.35 Million	-19,949 Reduced 21.03%	74,932 $4.57 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $994,615 - $1.25 Million	-21,903 Reduced 18.76%	94,881 $4.44 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $2.65 Million - $3.42 Million	62,206 Added 113.98%	116,784 $5.93 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $264,754 - $485,505	-8,179 Reduced 13.03%	54,578 $2.43 Million
Q4 2019 Feb 18, 2020	SELL	$32.22 - $50.07 $32,220 - $50,070	-1,000 Reduced 1.57%	62,757 $3.01 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $2.77 Million - $3.94 Million	-81,844 Reduced 56.21%	63,757 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $1.04 Million - $1.32 Million	-29,419 Reduced 16.81%	145,601 $6.55 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $560,760 - $788,338	19,963 Added 12.87%	175,020 $6.59 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $365,328 - $569,607	-12,247 Reduced 7.32%	155,057 $5.32 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $670,609 - $944,986	19,782 Added 13.41%	167,304 $7.86 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $3.79 Million - $7.06 Million	147,522 New	147,522 $4.98 Million

Others Institutions Holding PTCT

# of Institutions

284

Shares Held

78.5M

Call Options Held

223K

Put Options Held

156K

Vanguard Group Inc Valley Forge, PA

8.61M
Shares

$407 Million
0.01% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$367 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.48M
Shares

$354 Million
6.25% of portfolio
Armistice Capital, LLC New York, NY

5.43M
Shares

$257 Million
4.22% of portfolio
Wellington Management Group LLP Boston, MA

5.42M
Shares

$256 Million
0.05% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.38B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account